Skip to content

Clinical trials

Phase 3 Uterine Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Neoplasms Phase: Phase 3 Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20181
20191
20211
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Completed2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Karyopharm Therapeutics Inc1
Mabwell (Shanghai) Bioscience Co., Ltd.1
Queensland Centre for Gynaecological Cancer1
University College, London1
University of California, Irvine1
ZonMw: The Netherlands Organisation for Health Research and Development1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Neoplasms8
Endometrial Neoplasms5
Leiomyoma2
Neoplasms2
Neoplasms by Site2
Uterine Diseases2
Genital Diseases1
Genital Neoplasms, Female1
Menorrhagia1
Neoplasm Metastasis1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.